136 related articles for article (PubMed ID: 8543319)
1. The nuclear channel system in endometrial adenocarcinoma exposed to medroxyprogesterone acetate.
Horbelt DV; Delmore JE; Parmley TH; Roberts DK; Walker N
Hum Pathol; 1996 Jan; 27(1):9-14. PubMed ID: 8543319
[TBL] [Abstract][Full Text] [Related]
2. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.
Imai M; Jobo T; Sato R; Kawaguchi M; Kuramoto H
Eur J Gynaecol Oncol; 2001; 22(3):217-20. PubMed ID: 11501776
[TBL] [Abstract][Full Text] [Related]
3. Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Zaino RJ; Brady WE; Todd W; Leslie K; Fischer EG; Horowitz NS; Mannel RS; Walker JL; Ivanovic M; Duska LR
Int J Gynecol Pathol; 2014 Nov; 33(6):543-53. PubMed ID: 25272292
[TBL] [Abstract][Full Text] [Related]
4. While women await surgery for type I endometrial cancer, depot medroxyprogesterone acetate reduces tumor glandular cellularity.
Fiascone S; Danilack VA; Kao MJ; Cohen M; Singh K; Kalife E; Luis C; Lokich E; DiSilvestro P; Robison K
Am J Obstet Gynecol; 2018 Oct; 219(4):381.e1-381.e10. PubMed ID: 30063901
[TBL] [Abstract][Full Text] [Related]
5. Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma.
Fujiwara H; Shibahara H; Usui R; Takamizawa S; Kosuge S; Ohwada M; Suzuki M; Sato I
Am J Reprod Immunol; 2002 Mar; 47(3):129-31. PubMed ID: 12069197
[No Abstract] [Full Text] [Related]
6. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
Mao Y; Wan X; Chen Y; Lv W; Xie X
Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
[TBL] [Abstract][Full Text] [Related]
7. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
8. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Vinker S; Shani A; Open M; Fenig E; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):63-5. PubMed ID: 10221612
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal therapy in the treatment of endometrial adenocarcinoma].
Rob L
Ceska Gynekol; 1996 Aug; 61(4):249-50. PubMed ID: 8963496
[No Abstract] [Full Text] [Related]
10. Primary hormonal treatment for early endometrial carcinoma.
Sardi J; Anchezar Henry JP; Paniceres G; Gomez Rueda N; Vighi S
Eur J Gynaecol Oncol; 1998; 19(6):565-8. PubMed ID: 10215442
[TBL] [Abstract][Full Text] [Related]
11. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.
Kaku T; Yoshikawa H; Tsuda H; Sakamoto A; Fukunaga M; Kuwabara Y; Hataeg M; Kodama S; Kuzuya K; Sato S; Nishimura T; Hiura M; Nakano H; Iwasaka T; Miyazaki K; Kamura T
Cancer Lett; 2001 Jun; 167(1):39-48. PubMed ID: 11323097
[TBL] [Abstract][Full Text] [Related]
12. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger.
Ota T; Yoshida M; Kimura M; Kinoshita K
Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120
[TBL] [Abstract][Full Text] [Related]
14. Multicystic pulmonary metastases of endometrial carcinoma.
Beuselinck B; Weytjens K; Vanbockrijk M; Mebis J
Acta Clin Belg; 2005; 60(5):257-9. PubMed ID: 16398324
[No Abstract] [Full Text] [Related]
15. Sparing fertility in young patients with endometrial cancer.
Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
[TBL] [Abstract][Full Text] [Related]
16. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of atypical hyperplasia and adenocarcinoma of the endometrium with the combination of progestins and anticoagulants].
Adamian RT
Vopr Onkol; 2001; 47(3):359-62. PubMed ID: 11544839
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal therapy for endometrial adenocarcinoma].
Susumu N; Aoki D; Suzuki N; Nozawa S
Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
[TBL] [Abstract][Full Text] [Related]
19. Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.
Yunokawa M; Yoshida H; Watanabe R; Noguchi E; Shimomura A; Shimoi T; Yonemori K; Shimizu C; Fujiwara Y; Tamura K
Cancer Chemother Pharmacol; 2017 Jul; 80(1):127-134. PubMed ID: 28540420
[TBL] [Abstract][Full Text] [Related]
20. Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.
Kim DH; Seong SJ; Kim MK; Bae HS; Kim M; Yun BS; Jung YW; Shim JY
J Gynecol Oncol; 2017 Jan; 28(1):e1. PubMed ID: 27670255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
